Ge Yifei, Jiang Lixue, Yang Chengru, Dong Qingfu, Tang Chengwu, Xu Yi, Zhong Xiangyu
Department of Hepatopancreatobiliary Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Department of Breast Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Front Oncol. 2024 Nov 7;14:1449696. doi: 10.3389/fonc.2024.1449696. eCollection 2024.
Tumor-associated macrophages (TAMs) play a pivotal role in sculpting the tumor microenvironment and influencing cancer progression, particularly through their interactions with various forms of regulated cell death (RCD), including apoptosis, pyroptosis, ferroptosis, and necroptosis. This review examines the interplay between TAMs and these RCD pathways, exploring the mechanisms through which they interact to promote tumor growth and advancement. We examine the underlying mechanisms of these intricate interactions, emphasizing their importance in cancer progression and treatment. Moreover, we present potential therapeutic strategies for targeting TAMs and manipulating RCD to enhance anti-tumor responses. These strategies encompass reprogramming TAMs, inhibiting their recruitment, and selectively eliminating them to enhance anti-tumor functions, alongside modulating RCD pathways to amplify immune responses. These insights offer a novel perspective on tumor biology and provide a foundation for the development of more efficacious cancer therapies.
肿瘤相关巨噬细胞(TAMs)在塑造肿瘤微环境和影响癌症进展方面发挥着关键作用,特别是通过它们与各种形式的程序性细胞死亡(RCD)相互作用,包括凋亡、焦亡、铁死亡和坏死性凋亡。本综述探讨了TAMs与这些RCD途径之间的相互作用,探究它们相互作用以促进肿瘤生长和进展的机制。我们研究了这些复杂相互作用的潜在机制,强调它们在癌症进展和治疗中的重要性。此外,我们提出了针对TAMs和调控RCD以增强抗肿瘤反应的潜在治疗策略。这些策略包括对TAMs进行重编程、抑制它们的募集以及选择性地消除它们以增强抗肿瘤功能,同时调节RCD途径以放大免疫反应。这些见解为肿瘤生物学提供了新的视角,并为开发更有效的癌症治疗方法奠定了基础。